Burns Clinical Trial
Official title:
Critical Smoke Alarm Characteristics to Awaken Children From Stage 4 Sleep
Verified date | November 2019 |
Source | Nationwide Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Specific Aim 1 is to test the hypothesis that there are specific characteristics of a voice
smoke alarm (i.e., use of child's first name, behavior commands in the message content, use
of mother's voice, and stimulus frequency) that will awaken children 5-12 years old in stage
4 sleep. The successful children's alarm will be tested among adult subjects to evaluate
effectiveness across the age spectrum.
Specific Aim 2 is to test the hypothesis that there are specific characteristics of a voice
smoke alarm (i.e., use of mother's voice and behavior commands in the message content) that
will result in successful completion of simulated escape behaviors by children 5-12 years old
after awakening from stage 4 sleep. The successful children's alarm will be tested among
adult subjects to evaluate effectiveness across the age spectrum.
Status | Completed |
Enrollment | 834 |
Est. completion date | September 21, 2018 |
Est. primary completion date | September 21, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 5 Years to 84 Years |
Eligibility |
Inclusion Criteria: - Child is at least 5 years of age and has not yet had his/her thirteenth birthday (for Studies # 1, 2, and 5). - Subject (and child's caretaker for Studies #1, 2, and 5) speak English (2000 Census data indicate that less than 5% of the population older than five years of age in Franklin County, Ohio [where the study is located] speaks English less than "very well"). - Subject/family is able to be contacted by telephone (to obtain pre-study information and to remind the family about the study appointment and confirm that the child is in a normal state of health on day of study). - For adult study arms: Study 3: Subjects are 20-49 years of age; Study 4: Subjects are 60-84 years of age. Exclusion Criteria: - Subject has a clinical diagnosis that may affect sleep, arousal or ability to perform the escape procedure. - Subject has a hearing impairment. - Subject is taking medication that may affect sleep, arousal, or ability to perform the escape procedure. - Subject has an acute illness at the time of the sleep study. The target population for Study 3 consists of adults 20-49 years of age, who have not yet had his/her fiftieth birthday. Adult participants must not have a clinical diagnosis that may affect sleep, arousal or ability to perform the simulated escape procedure. He/she must not have a hearing impairment; not be taking medication that may affect sleep, arousal, or ability to perform the escape procedure; and not have an acute illness at the time of the sleep study. The adult must speak English and be able to be contacted by telephone (to obtain pre-study information and to remind the participant about the study appointment and confirm that he/she is in a normal state of health on the day of the study). The target population for Study 4 consists of older adults 60-84 years of age, who have not yet had his/her eighty-fifth birthday. The older adult must not have a clinical diagnosis that may affect sleep, arousal or ability to perform the escape; not have a hearing impairment; and not be taking medication that may affect sleep, arousal, or ability to perform the simulated escape procedure. The older adult must not have an acute illness at the time of the sleep study. The older adult must speak English and be able to be contacted by telephone (to obtain pre-study information and to remind the participant about the study appointment and confirm that he/she is in a normal state of health on the day of the study). The target population for Study 5 is the same as that for Studies 1 and 2. |
Country | Name | City | State |
---|---|---|---|
United States | The Research Institute at Nationwide Children's Hospital | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Nationwide Children's Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Awaken (Yes/No) | Subject awakened by alarm (Yes/No) | Day 1 - Immediately following each alarm | |
Primary | Escape (Yes/No) | Subject successfully performed simulated escape procedure (Yes/No) | Day 1 - Immediately following each alarm | |
Primary | Time to awaken | Time from onset of alarm until EEG-defined awakening | Day 1 - Immediately following each alarm | |
Primary | Time to Escape | Time from onset of alarm until child exits sleep room | Day 1 - Immediately following each alarm | |
Secondary | Reaction time | Sleep inertia will be quantitatively measured using a Psychomotor Vigilance Task Monitor device (PVT-192 by Ambulatory Monitoring, Inc.) after subjects awaken. | Day 1 - Immediately after awakening |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Completed |
NCT05276869 -
Reliability and Feasibility of WeeFIM Instrument to Measure Functional Independence in Pediatric Burns
|
||
Completed |
NCT04548635 -
VR for Burn Dressing Changes at Home
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT06076031 -
Effects of Applying Streaming Media on Reducing Pain in Patient With Second-degree Burn During Changing Dressing
|
N/A | |
Recruiting |
NCT05084248 -
Vitamin D Deficiency in Adults Following a Major Burn Injury
|
Phase 4 | |
Completed |
NCT03113253 -
TRANexamic Acid to Reduce Bleeding in BURN Surgery
|
Phase 4 | |
Recruiting |
NCT04090424 -
Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT03159182 -
Study of Silicone Material Inserts To Treat Burn Scars
|
N/A | |
Recruiting |
NCT02904941 -
Human Amniotic Versus Synthetic Membrane as a Transient Skin Cover for Pediatric Burns
|
N/A | |
Completed |
NCT02681757 -
Comparison of Mepitel Ag vs Antibiotic Ointment Used With Soft Cast Technique for Treatment of Pediatric Burns
|
N/A | |
Recruiting |
NCT01812941 -
Evaluation of Mitochondrial Dysfunction in Severe Burn and Trauma Patients
|
N/A | |
Completed |
NCT01437852 -
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
|
Phase 1 | |
Completed |
NCT01214811 -
Open Multi-centre Investigation to Evaluate Signs and Symptoms of Local Inflammation/Infection on Chronic Ulcers and Partial Thickness Burns When Using Mepilex Border Ag as an Anti-microbial Wound Dressing
|
Phase 3 | |
Completed |
NCT01061502 -
Efficacy Study of a Bioelectric Dressing to Treat Skin Graft Donor Site Wounds
|
Phase 1/Phase 2 | |
Terminated |
NCT00822796 -
Thermogard™ Efficacy Trial
|
N/A | |
Terminated |
NCT00634166 -
Effects of Therapy With Sulfamylon® 5% Topical Solution Compared to a Historical Control Group
|
Phase 4 | |
Terminated |
NCT00824681 -
Effect of Music Therapy on Families of Burn Patients
|
Phase 1 | |
Terminated |
NCT00464386 -
Continuous Glucose Monitoring (POC) in the ICU
|
N/A | |
Withdrawn |
NCT00216983 -
Proline Metabolism in Severely Burned Patients: Effect of Modulated Parenteral Feeding
|
N/A |